Search Results - "Dreja, H"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    PO-146 Knockout validation of antibodies to components of the NF-kB signalling pathway by Dreja, H, Block, G De, Heaton, S, Conlon, D, Rizzo, J, Warwick, E, Pesaresi, M, Ayton, J, Solache, A

    Published in ESMO open (01-07-2018)
    “…IntroductionNuclear factor-κB (NF-κB) plays a pivotal role in inflammation and innate immunity and aberrant regulation of NF-κB can influence cancer…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Induction of Long-Term Protective Antiviral Endogenous Immune Response by Short Neutralizing Monoclonal Antibody Treatment by GROS, Laurent, DREJA, Hanna, LAURE FISER, Anne, PLAYS, Marc, PELEGRIN, Mireia, PIECHACZYK, Marc

    Published in Journal of Virology (01-05-2005)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells by Bachrach, Estanislao, Dreja, Hanna, Lin, Yea-Lih, Mettling, Clément, Pinet, Valérie, Corbeau, Pierre, Piechaczyk, Marc

    Published in Virology (New York, N.Y.) (05-02-2005)
    “…The quantity of envelope glycoprotein molecules (Env) on HIV-1 particles is still an issue of debate and, depending on the strain of virus and the nature of…”
    Get full text
    Journal Article
  5. 5

    A novel doxycycline inducible autoregulatory plasmid which displays 'on'/'off' regulation suited to gene therapy applications by GOULD, D. J, BERENSTEIN, M, DREJA, H, LEDDA, F, PODHAJCER, O. L, CHERNAJOVSKY, Y

    Published in Gene therapy (01-12-2000)
    “…The development of transcriptionally controlled systems which function in eukaryotic cells are important for achieving regulated gene expression in gene…”
    Get full text
    Journal Article
  6. 6

    Monoclonal antibody-based genetic immunotherapy by Pelegrin, Mireia, Gros, Laurent, Dreja, Hanna, Piechaczyk, Marc

    Published in Current gene therapy (01-09-2004)
    “…The clinical application potential of monoclonal antibodies concerns a wide range of diseases including, among others, viral infections, cancer and autoimmune…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Immuno- and genetic therapy in autoimmune diseases by Chernajovsky, Y, Dreja, H, Daly, G, Annenkov, A, Gould, D, Adams, G, Croxford, J L, Baker, D, Podhajcer, O L, Mageed, R A

    Published in Genes and immunity (01-06-2000)
    “…Animal models of autoimmune disease have been developed that mimic some aspects of the pathophysiology of human disease. These models have increased our…”
    Get full text
    Journal Article
  9. 9

    Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis by Rabinovich, G A, Daly, G, Dreja, H, Tailor, H, Riera, C M, Hirabayashi, J, Chernajovsky, Y

    Published in The Journal of experimental medicine (02-08-1999)
    “…Galectin-1 (GAL-1), a member of a family of conserved beta-galactoside-binding proteins, has been shown to induce in vitro apoptosis of activated T cells and…”
    Get full text
    Journal Article
  10. 10

    Targeting cytokines to inflammation sites by Vessillier, Sandrine, Chernajovsky, Yuti, Adams, Gill, Dreja, Hanna

    Published in Nature biotechnology (01-11-2003)
    “…To increase the half-life of a cytokine and target its activation specifically to disease sites, we have engineered a latent cytokine using the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The effects of N-terminal insertion into VSV-G of an scFv peptide by Dreja, Hanna, Piechaczyk, Marc

    Published in Virology journal (02-09-2006)
    “…Recombinant retroviruses, including lentiviruses, are the most widely used vectors for both in vitro and in vivo stable gene transfer. However, the inability…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    Gene therapy for rheumatoid arthritis: Theoretical considerations by CHERNAJOVSKY, Y, ANNENKOV, A, BAKER, D, HERMAN, C, TRIANTAPHYLLOPOULOS, K, GOULD, D, DREJA, H, MOYES, S. P, CROXFORD, J. L, MAGEED, R. A, PODHAJCER, O. L

    Published in Drugs & aging (1998)
    “…Current understanding of the pathogenesis of rheumatoid arthritis has provided evidence that therapeutic benefit can be achieved by using antagonists targeted…”
    Get full text
    Journal Article
  18. 18

    Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen‐induced arthritis by Dreja, Hanna, Annenkov, Alex, Chernajovsky, Yuti

    Published in Arthritis and rheumatism (01-08-2000)
    “…Objective The complement system is important in the development of autoimmune inflammation, including rheumatoid arthritis (RA) and collagen‐induced arthritis…”
    Get full text
    Journal Article
  19. 19